Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Breakthrough drug trial aims to stop Cholera's deadly dehydration

NCT ID NCT06193408

Summary

This study tested whether a new drug called VR-AD-1005 could help control severe diarrhea in cholera patients. Researchers compared the drug against a placebo in 150 adults with confirmed cholera to see if it reduced stool output and the need for IV fluids. If effective, this treatment could shorten hospital stays and reduce antibiotic use, helping fight antibiotic resistance.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHOLERA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Icddr,b

    Dhaka, Bangladesh

Conditions

Explore the condition pages connected to this study.